Back

Cardiorenal trade-off of sacubitril/valsartan in heart failure with reduced ejection fraction and advanced chronic kidney disease: a propensity-weighted multicentre analysis

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Chien-Yi Hsu

Taipei Medical University Hospital, Taipei (Taiwan)

7 More presentations in this session

Presentation thumbnail
Impact of cumulative contrast volume on medium- to long-term renal function in patients undergoing repeated percutaneous coronary interventions
Doctor P. Steinhoff (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of echocardiographic cardiac deterioration after arteriovenous access surgery
Doctor L. Fisher (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Longitudinal change in epicardial adipose tissue attenuation on serial non-contrast chest CT in finerenone-treated patients: a real-world cohort study
Doctor X. Zhang (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
CV inflammation prevalence and clinical biomarkers (hsCRP, IL-6 and NT-proBNP) levels in adults with ASCVD and CKD in KSA and UAE: Insights from the INFLAMEAST real‑world study
Doctor M. Alasnag (Jeddah, SA)
Abstract Slides Video
Presentation thumbnail
Glp-1 receptor agonists and cardiovascular outcomes in obese patients on dialysis:insights –from the TriNetX real-world database
Mrs B. Prado (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of chronic kidney disease and renal safety of contemporary therapies in patients with heart failure: a real-world analysis
28 August 2026
thumbnail
Congress Presentation
Renal Outcomes in PARAGLIDE-HF and PARAGON-HF
25 August 2023
thumbnail
Congress Presentation
Long-term cardiovascular outcomes across KDOKI risk categories in a large Asian cohort
30 August 2026
thumbnail
Congress Presentation
Efficacy and safety of sacubitril/valsartan in the management of heart failure with reduced ejection fraction and chronic kidney disease: a systematic review and meta-analysis
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources